Evolving role of entrectinib in treatment of NTRK -positive tumors.

MLA

Chawla, Neal, et al. “Evolving Role of Entrectinib in Treatment of NTRK -Positive Tumors.” Future Oncology (London, England), vol. 17, no. 22, Aug. 2021, pp. 2835–46. EBSCOhost, https://doi.org/10.2217/fon-2020-0936.

APA

Chawla, N., Bui, N. Q., & Seetharam, M. (2021). Evolving role of entrectinib in treatment of NTRK -positive tumors. Future Oncology (London, England), 17(22), 2835–2846. https://doi.org/10.2217/fon-2020-0936

Chicago

Chawla, Neal, Nam Q Bui, and Mahesh Seetharam. 2021. “Evolving Role of Entrectinib in Treatment of NTRK -Positive Tumors.” Future Oncology (London, England) 17 (22): 2835–46. doi:10.2217/fon-2020-0936.